Theragnostics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.5M

Theragnostics General Information

Description

Developer of molecular radiotherapy and molecular imaging diagnostic products designed for the treatment of cancer patients. The company's radioactive labeled drugs help to improve patient outcomes by providing physicians access to the superior sensitivity and specificity of PET imaging, enabling clinicians to handle both the management and treatment of cancer patients, from initial diagnosis through response to therapy.

Contact Information

Formerly Known As
Accretion Biotechnology, Imaging Equipment Research
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 21 Gloucester Place
  • London W1U 8HR
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Other Industries
Pharmaceuticals
Drug Discovery
Other Healthcare Technology Systems
Acquirer
Vertical(s)
Corporate Office
  • 21 Gloucester Place
  • London W1U 8HR
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theragnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jun-2023 $2.5M Completed Generating Revenue
4. Later Stage VC 21-May-2021 Completed Generating Revenue
3. Later Stage VC 28-Dec-2019 Completed Clinical Trials - Phase 2
2. Early Stage VC 31-Aug-2017 $3.69M $3.69M Completed Clinical Trials - Phase 1
1. Grant 01-Jun-2016 $910K Completed Startup
To view Theragnostics’s complete valuation and funding history, request access »

Theragnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Theragnostics’s complete cap table history, request access »

Theragnostics Patents

Theragnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201504064-D0 Method and kits for preparing radionuclide complexes Inactive 10-Mar-2015
AU-2016230890-A1 Methods and kits for preparing radionuclide complexes Active 10-Mar-2015
AU-2016230890-B2 Methods and kits for preparing radionuclide complexes Active 10-Mar-2015
CA-2979127-A1 Methods and kits for preparing radionuclide complexes Active 10-Mar-2015
CA-2979127-C Methods and kits for preparing radionuclide complexes Active 10-Mar-2015 C07F5/003
To view Theragnostics’s complete patent history, request access »

Theragnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Theragnostics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government
To view Theragnostics’s complete investors history, request access »

Theragnostics FAQs

  • When was Theragnostics founded?

    Theragnostics was founded in 2013.

  • Where is Theragnostics headquartered?

    Theragnostics is headquartered in London, United Kingdom.

  • What is the size of Theragnostics?

    Theragnostics has 8 total employees.

  • What industry is Theragnostics in?

    Theragnostics’s primary industry is Diagnostic Equipment.

  • Is Theragnostics a private or public company?

    Theragnostics is a Private company.

  • What is the current valuation of Theragnostics?

    The current valuation of Theragnostics is .

  • What is Theragnostics’s current revenue?

    The current revenue for Theragnostics is .

  • How much funding has Theragnostics raised over time?

    Theragnostics has raised $11.4M.

  • Who are Theragnostics’s investors?

    Innovate UK has invested in Theragnostics.

  • When was Theragnostics acquired?

    Theragnostics was acquired on 01-Jun-2023.

  • Who acquired Theragnostics?

    Theragnostics was acquired by Ariceum.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process